Clinical trial Recruiting at 1 site Observational Women only

Cerebroplacental ratio discordance at 16–20 weeks to predict complications in monochorionic diamniotic twins

Official title: Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complications : a Prospective Cohort Study

Run by Ain Shams Maternity Hospital · NCT06935422 · Data updated 2026-11-12

This study tests whether differences in cerebroplacental ratio between twins at 16–20 weeks can help predict TTTS, TAPS, selective fetal growth restriction, or fetal death in monochorionic diamniotic pregnancies.

More Monochorionic Twins trials

Quick facts

Study typeObservational
SexWomen only
Enrollment55 (estimated)
SponsorAin Shams Maternity Hospital
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedAugust 1, 2026
Study endsSeptember 15, 2026
Registry record updatedSeptember 5, 2025
Trial IDNCT06935422 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with confirmed monochorionic diamniotic twin pregnancies and inter-twin CPR discordance at 16–20 weeks who can consent to follow-up at the site.

Probably not a fit

Patients with fetal structural or chromosomal abnormalities, infectious causes of growth restriction, single fetal demise at enrollment, conjoint twins, or who are referred after development of TTTS/TAPS/sFGR are unlikely to benefit from this predictive approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort study that measures inter-twin cerebroplacental ratio (CPR) discordance by ultrasound at 16–20 weeks gestation in monochorionic diamniotic twin pregnancies. Participants with CPR discordance are followed through pregnancy for development of monochorionic-specific complications including twin-to-twin transfusion syndrome (TTTS), twin anemia polycythemia sequence (TAPS), selective fetal growth restriction (sFGR), and intrauterine fetal death (IUFD). Outcome rates in pregnancies with early CPR discordance will be compared to expectations to estimate predictive value. No experimental treatments are given and clinical care follows standard practice at the recruiting center.

Why it matters

Potential benefit: If successful, early identification of CPR discordance could enable targeted surveillance and earlier interventions for high-risk monochorionic twin pregnancies, potentially reducing adverse outcomes.

How similar studies have gone: Sparse prior studies have suggested that early inter-twin Doppler differences can precede clinical TTTS, TAPS, or sFGR, but evidence is limited and larger confirmatory studies are lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 years or more and able to consent.
* Monochorionic Diamniotic twin pregnancy.
* Discordant inter-twin cerebroplacental ratio at 16-20 weeks of gestation.

Exclusion Criteria:

* Fetal structural malformations or chromosomal abnormalities in any of the twins as detected by anomaly scan antenatally or neonatal examination postnatally (chromosomal abnormalities and some congenital malformations can interfere with normal fetal growth).
* Identified infectious etiologies detected during immediate postnatal examination or during pregnancy (fetal infections can cause FGR ,usually symmetric type particularly if they occur in early gestation).
* Referral after development of Twin to twin transfusion syndrome, twin anemia polycythemia sequence or selective fetal growth restriction.
* Single fetal demise at the time enrollment in the study.
* Conjoint twins.

Where it's running

  • Ain shams maternity hospital
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Placental characteristics in monochorionic twins

    This project will see how placental anatomy relates to outcomes for families with monochorionic twins by analyzing placentas after birth at a Birmingham NHS site.

    Recruiting Birmingham Women's NHS Foundation Trust · Birmingham, West Midlands · NCT07124312

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.